Lung transplantation for lymphangioleiomyomatosis
- 8 October 2022
- journal article
- review article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (1) , 40-52
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- The efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosisRespiratory Investigation, 2013
- Lymphangioleiomyomatosis — a wolf in sheep’s clothingJournal of Clinical Investigation, 2012
- Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosisRespiratory Research, 2012
- Efficacy and Safety of Sirolimus in LymphangioleiomyomatosisNew England Journal of Medicine, 2011
- Lung Transplantation for Pulmonary HypertensionPulmonary Circulation, 2011
- mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxiaThe FASEB Journal, 2011
- Melanoma-Associated Antigen Expression in Lymphangioleiomyomatosis Renders Tumor Cells Susceptible to Cytotoxic T CellsThe American Journal of Pathology, 2009
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- Pulmonary Artery Pressure in LymphangioleiomyomatosisChest, 2007
- Survival and disease progression in UK patients with lymphangioleiomyomatosisThorax, 2004